1 / 8

NSCLC Approved 1st & 2nd Line Rx

NSCLC Approved 1st & 2nd Line Rx. Vinorelbine vs 5-FU/LV. Navelbine/cisplatin. Gemcitabine/cisplatin. Paclitaxel/cisplatin. Docetaxel/cisplatin. Docetaxel - 2nd line. Summary. 4 cisplatin doublets and single agent vinorelbine approved for first-line treatment of advanced NSCLC

benoit
Télécharger la présentation

NSCLC Approved 1st & 2nd Line Rx

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. NSCLC Approved 1st & 2nd Line Rx

  2. Vinorelbine vs 5-FU/LV

  3. Navelbine/cisplatin

  4. Gemcitabine/cisplatin

  5. Paclitaxel/cisplatin

  6. Docetaxel/cisplatin

  7. Docetaxel - 2nd line

  8. Summary 4 cisplatin doublets and single agent vinorelbine approved for first-line treatment of advanced NSCLC Approval based on superior survival (3), non-inferior survival (1), Superior TTP & RR with a survival trend (1).

More Related